CellSeed Inc
TSE:7776

Watchlist Manager
CellSeed Inc Logo
CellSeed Inc
TSE:7776
Watchlist
Price: 489 JPY -0.41% Market Closed
Market Cap: 16.9B JPY
Have any thoughts about
CellSeed Inc?
Write Note

EV/EBIT
Enterprise Value to EBIT

-17.8
Current
-8
Median
3.8
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-17.8
=
Enterprise Value
14.3B JPY
/
EBIT
-802.7m JPY
All Countries
Close
Market Cap EV/EBIT
JP
CellSeed Inc
TSE:7776
16.4B JPY -17.8
FR
Pharnext SCA
OTC:PNEXF
6T USD -213 281.4
US
Abbvie Inc
NYSE:ABBV
302.3B USD 22.9
US
Amgen Inc
NASDAQ:AMGN
160.6B USD 33.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.3B USD 28
US
Gilead Sciences Inc
NASDAQ:GILD
118.3B USD 10.4
US
Epizyme Inc
F:EPE
94.1B EUR -509.7
AU
CSL Ltd
ASX:CSL
138.5B AUD 26.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
90.4B USD 19.9
US
Seagen Inc
F:SGT
39.3B EUR -54
NL
argenx SE
XBRU:ARGX
33.4B EUR -74.9
EBIT Growth
JP
CellSeed Inc
TSE:7776
Average EV/EBIT: 23.5
Negative Multiple: -17.8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -213 281.4 N/A
US
Abbvie Inc
NYSE:ABBV
22.9
88%
US
Amgen Inc
NASDAQ:AMGN
33.4
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -509.7 N/A
AU
CSL Ltd
ASX:CSL
26.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -74.9 N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
N/A
2-Years Forward
EV/EBIT
N/A
3-Years Forward
EV/EBIT
N/A

See Also

Discover More